NASDAQ:CTKB | Cash Flow Statement | Cytek Biosciences, Inc.

Complete source-backed cash-flow history.

Available history
2020-03-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$12.16M
2026-03-31-$18.87M$1.87M-$2.74M$2.17M-$27.08M$0.00$3.98M
2025-12-31-$44.08M$1.9M-$771,000.00$1M-$1.84M-$34,000.00-$1.23M
2025-09-30-$5.48M
2025-06-30-$5.58M
2025-03-31-$11.4M$1.88M-$125,000.00$849,000.00$9.45M$10.63M-$11.55M
2024-12-31$9.64M$1.85M$2M$894,000.00-$63.43M$6.99M-$3.64M
2024-09-30$941,000.00$11.9M
2024-06-30-$10.43M$2.7M
2024-03-31-$6.17M$1.7M$3.96M$567,000.00-$5.75M$0.00$1.61M
2023-12-31$5.5M$1.63M$9.51M$1.5M$29.07M$34.6M-$33.75M
2023-09-30-$6.46M
2023-06-30-$4.39M
2023-03-31-$6.81M$1M$2.86M$505,000.00-$168.87M$0.00
2022-12-31$3.72M$761,000.00$6.19M$6.53M-$51.06M$3.85M
2022-09-30$1.63M
2022-06-30-$702,000.00
2022-03-31-$2.16M$794,000.00-$1.48M$780,000.00-$780,000.00$364,000.00
2021-12-31-$1.17M$685,000.00$5.45M$1.3M-$18.3M$17,000.00
2021-09-30$1.42M
2021-06-30$2.67M
2021-03-31$102,000.00$167,000.00$1.94M$509,000.00-$138,000.00$187,000.00
2020-12-31$5.6M$158,000.00$11.64M$203,000.00-$203,000.00$119.73M
2020-09-30$6.54M
2020-06-30$8.11M
2020-03-31-$839,000.00

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$66.54M$7.58M-$4.69M$4.08M$10.12M$15.07M-$13.43M
2024-12-31-$6.02M$7.21M$25.38M$3.53M-$82.97M$21.61M-$15.82M
2023-12-31-$12.15M$6.05M$5.28M$4.65M-$93.89M$44.15M-$41.81M
2022-12-31$2.48M$2.49M-$12.23M$9.75M-$55.91M$0.00$5.51M
2021-12-31$3.03M$1.24M$4.63M$4.36M-$20.99M$0.00$213.56M
2020-12-31$19.41M$603,000.00$15.16M$1.55M-$1.55M$122.61M